BioTheryX
Latest round
- Series E
Last raised
- May 2021
Total raised
- $127M
Investors
- 13
About BioTheryX
Based in New York, US and founded in 2008, BioTheryX Inc. is a developer of anti-cancer drugs to treat a broad range of therapeutic areas including oncology, inflammation, and other diseases. As of August 2021, David Stirling is the president and CEO of the company. The company offers multiple products, including BTX-2640 for Inflammation and Oncology, BTX-1188 for AML and MDS, BTX-1050 for Immune Modulation, Oncology, BTX-A51 for AML, MDS, Solid Tumors, PHMs for Autoimmune Diseases and Immuno-Oncology, and BTX-2541 for Cancers. Also, the company provides technology platform centers, including PHMs, PHM-PTCs, and Multi-Kinase Inhibitor P53 protein modulation focusing on degrading proteins to create life-saving medicines. The Protein Homeostatic Modulators (PHM) technology of the company utilizes a protein disposal system of the body to remove and degrade disease-causing proteins. Also, the company plans to reach milestones in Phase 1 lead multi-kinase inhibitor BTX-A51and IND-enabling molecular glue program BTX-1188 by the end of 2021.
Who invested in BioTheryX
13 investors across 2 rounds
See all investors in BioTheryX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioTheryX
Who invested in BioTheryX?
BioTheryX has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioTheryX raised?
BioTheryX has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did BioTheryX last raise money?
BioTheryX's most recent round on record is a Series E, in May 2021.
What does BioTheryX do?
Based in New York, US and founded in 2008, BioTheryX Inc.
Where is BioTheryX headquartered?
BioTheryX is headquartered in San Diego, US.
Which VCs invest in companies like BioTheryX?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioTheryX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like BioTheryX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.